2FMA 30 MG Pellets (2-Fluoroamphetamine) – Scientific Product Description

Introduction

2fma (2-Fluoroamphetamine) is a research chemical of the phenethylamine class, characterized by un fluorine substitution at the ortho position of the phenyl ring. These 30 mg pellets are designed for standardized use in controlled pharmacological and neurochemical studies. Use is permitted only in legally recognized laboratory settings.

Propriétés chimiques

• Systematic name: 1-(2-fluorophenyl)-2-aminopropane
• Formule moléculaire : C₉H₁₂FN
• Masse moléculaire: 153.20 g/mol
• Pureté: ≥98.5% (UPLC-MS/MS verified)
• Physical form: Round tablets (pellets)
• Pellet characteristics:
  • Diamètre : 5 mm
  • Hardness: 50–70 N
  • Disintegration time: <15 minutes (in vitro)
• Solubilité: Good in methanol and ethanol, moderate in water

Contrôle de qualité

Chaque lot est soumis à :

1. HPLC-DAD quantitative analysis
2. HRMS identity verification
3. Uniformity analysis (n=20)
4. Dissolution test (according to USP apparatus II)
5. Microbiological assessment according to Ph. Eur. standards

Applications de recherche 2FMA

2-FMA is investigated in the following contexts:

• Reuptake inhibition on dopamine and noradrenaline transporters
• Comparative structural-pharmacological analysis within fluoramphetamines
• Behavioral research in preclinical models
• In vitro metabolism and enzyme interaction studies

Protocoles de sécurité

Personal protective equipment:

• Chemical resistant nitrile gloves
• Type 5/6 protective clothing
• FFP3 respirator mask
• lunettes de sécurité

Working conditions:

• Fume hood with air velocity ≥0.5 m/s
• Antistatic work surfaces
• Temperature control: 15–25°C

Conditions de stockage :

• Dry, dark, and in gas-tight blister packaging
• Temperature: 15–25°C
• Relative humidity: <60%
• Recommended under inert gas (argon or nitrogen)

Cadre réglementaire

• Netherlands: Classified under the Opium Act – Schedule II
• International: Subject to regulation as a new psychoactive substance (NPS)
• WADA status: Prohibited under category S6 (stimulants)
• Use: For accredited, licensed research institutions only

Distribution and Delivery

• Minimum order quantity: 10 pastilles
• Conditionnement: Blister packed per pellet, light and airtight
• Transport: Certified cold chain (15–25°C), with temperature logging
• Included documentation:
  • Batch-specific Certificate of Analysis (COA)
  • Stability Report
  • Fiche de données de sécurité (FDS)

Scientific Sources 2FMA

• European Monitoring Center for Drugs and Drug Addiction (EMCDDA, 2023)
• Journal de psychopharmacologie (2022)
• Neuropharmacologie (2021)

Legal Disclaimer

This product is intended solely for scientific research by qualified professionals within authorized facilities. Verification of legal status and compliance with applicable laws is the responsibility of the purchaser. Unauthorized use is prohibited and may result in legal penalties. écorce de racine d'iboga​ acheter de l'ibogaïne hcl en ligne1 cp lsd o-dsmt 1vlsd